"I have worked with many consulting companies during my 11 years in the industry, and this was by far the best experience I have had."
— Client, Genentech
"I was very impressed with the level of industry knowledge...It was a pleasure to work with the team."
— Client, Pfizer
"I was somewhat cynical about the use of outside consultants...but Campbell Alliance is one of the few consulting companies that...creates real, value-added deliverables that move the initiative forward."
— Client, Amgen
"Prior to working with Campbell Alliance, I was a devotee of (another firm). You can count me officially as a convert..."
— Client, Valeant
Brand Management
- Market Opportunity Assessment for Oncology Assets
- Rescoping Defined Principles and Processes
- Trade-Off Testing
- Marketing Support
- Pediatric Launch
- Disease Area Segmentation
- Regional Planning-Brand Planning Integration
- US Oncology Launch Playbook®
- Commercial Representation of Core Team Handbook
- Opportunity Assessment Refinement
- Oncology Franchise Integration and Implementation
- Pen Launch Readiness Plan
- Co-Positioning Workshop
- End-of-Phase II Planning
- Chronic and Breakthrough Pain Treatment Flow Model
- Product Strategic Plan
- Appropriate Utilization of Access Solutions
- Competitive Landscape Executive Presentation
- Launch Playbook®
- Lifecycle Management Workshop
- Autoimmune Disease Patient Buying Process
- Global Strategic Plan
- Launch Playbook
- Global Strategic Plan Development
- Slide Library
- Low Volume Launch Playbook
- Pediatric Product Launch
- Oncology Pipeline Commercial Development Team Onboarding Tool
- Go To Market Model
- Internal Commercial Viability Presentation
- Launch Playbook Management
- War Gaming and Launch Management
- Oncology Franchise Integration and Roll-Out
- Autoimmune Product Analog Research
- Pharmaceutical Platform Initiative Phase I
- Market Development Benchmarking
- UK Launch Strategy
- Canadian Launch Playbook®
- Product Hospital Strategy
- Global Commercialization Strategy
- Consolidated Access Launch Playbook
- Medical Affairs Strategy
- Oncology Summit
- Expanded Indication Product Launch Planning and Support
- Endocrinology Portfolio Assessment
- Product Strategy Development
- Launch Playbook®
- Launch Playbook®
- Disease State Education Program: Project Management Support
- Brand Diagnostic
- Launch Management Support
- Brand Diagnostic
- Disease State Key Opinion Leader Profiling
- MSL Utilization and Benchmarking
- Go To Market Model
- Product Launch Playbook
- Product Launch Playbook
- Oncology Market Assessment
- Pain Portfolio Business Plan
- War Gaming and Launch Management
- Launch Playbook Support
- Opportunity Assessment
- Product Analog Case Studies
- Tumor Assessment Framework
- Commercialization Planning Phase II
- Corporate Strategy
- Launch Playbook
- Market Opportunity Assessment
- Market Opportunity Assessment
- Competitive Intelligence Monitoring Capability
- Launch Monitoring
- Launch Transition Plan
- Commercial Planning Phase I
- Winning Oncology Label
- Education Development for Oncology National Accounts
- Key Opinion Leader Plan
- Oncology Brand Book Planning
- Best Practice Sharing for European Markets
- Market Landscape Assessment
- Life Cycle Management Strategy
- Customer Relationship Management Strategy Development and Execution
- Market Shadow Brand Plans and Competitive Gaming Summit
- Canadian Deep Dive for Launch Readiness
- Shadow Brand Plan and Competitive Gaming Exercise
- Launch Playbook
- Launch Playbook and Scenario Planning
- Tumor Specific Validation
- Indication Prioritization
- KOL Strategy Enhancement
- Launch Support Phase II
- KOL Plan Development
- Disease State Market Assessment
- ISPs and Global Summit
- Launch Support
- Program Enhancement
- Therapeutic Oncology Franchise Development
- Disease State Assessment
- Launch Playbook
- Launch Playbook Update
- Product Buying Process
- Customer Satisfaction Program
- Scientific Affairs Roadshow
- US Launch Playbook
- Disease State Opportunity Assessment
- Oncology Pipeline Commercial Team Handbook
- Competitive Gaming
- Shadow Brand Plan and Competitive Gaming
- Opportunity Prioritization
- Global Launch Playbook
- Three-Year Brand Plan
- Health Economics Capability Development
- BioOncology Operations Plan
- Supportive Care Tactical Planning
- Opportunity Assessment
- Target Product Profile Development
- Therapeutic Oncology Franchise Development
- Portfolio Strategy Initiative
- Market Opportunity Assessment
- Competitive Game
- Analog Development
- Brand Planning Process
- Co-Promotion Launch Support
- Product Marketing Strategy
- Commercial Assessment
- Senior Management Presentation
- Winning Oncology Label
- Health Economics Handbook Development
- KOL Plan Development
- US Brand Plan
- Product Concept Development
- Brand Planning
- PMO Commercial Strategy
- Product Launch Playbook
- Product Forecast
- Launch Playbook
- Marketing Cost Estimates
- Corporate Value System
- Patient Flow Model
- EU Launch Playbook
- Target Product Profile Development
- Market Development Strategy
- Product Publication Planning
- Product Management
- Product Co-Pay Assistance Model
- Product Assessment
- Brand Strategy Analysis
- Therapeutic Area Assessment
- Brand Plan Template Development
- US Product Launch Playbook
- European Product Launch Playbook
- Product Launch Playbook for Expanded Indication
- New Product Launch Playbook
- Therapeutic Area Franchise Strategy
- Product Management Support
- Marketing Summit
- Therapeutic Area Franchise Plan
- Project Management Tool
- Two-Year Brand Plan
- Product Commercialization Plan
- Product Development Plan
- Commercial Strategy Phase II
- Patient Assistance Program
- Product Global Strategic Plan
- Product Competitive Game
- Developing Global Strategic Product Plan
- Developing Global Strategic Plan
- Developing Product Launch Strategy for Expanded Indication
- Product Strategic Plan
- Product Launch Management
- Product Canadian Launch Playbook
- Product Opportunity Analysis
- Product Opportunity Analysis
- Product Assessment for Expanded Indication Filing
- Product Launch Support
- Product Launch Support for Expanded Indication
- Product Brand Plan
- Consolidating Market Research
- Analogue Case Studies
- Developing Global Strategic Plan
- Commercial Planning and Product Franchise Strategy
- Product Program Management
- Practice Manager Advisory Board
- New Distribution Model Launch Preparation
- New Indication Launch Preparation
- Metrics Standardization
- Operations Plan Development
- Value Assessment
- Product Market Report
- Oncology Product Launch Managament
- Comprehensive Presentation Development for a Leading Biotech
- Therapeutic Oncology Franchise Strategy
- Launch Planning for a New Indication
- New Product Launch Guidance
- Assessment of Physician Speaker Program
- New Product Commerical Assessment
- Development and Management of Competitive Gaming Summit to Prepare for a New Product Launch
- Development of New Product Planning Processes
- Re-Launch of a Leading Biotech’s Reimbursement Support Services
- Opportunity Assessment
- Operating Plan Development
- Commercial Opportunity Assessment
- Publication Strategy Development
- Reimbursement and Distribution Model Assessment
- Drug Integration into Physician Practices
- Launch Plan Development
- Pipeline Product Launch Plan
- Marketing Tool Development
- Senior Care Products Managers Meeting
- Medical Affairs Team Update
- New Packaging Configuration Launch
- Activity Plan Development
- Development and Communication of Key Vision
- New Product Launch
- Simultaneous Management of Product Launches in the US and Germany
- Expert Product Launch Planning
- Strategic Evaluation Planning
- Development of Advisory Boards to Formulate Pre-Launch Strategy
- Support of a Marketing Team During a Critical Time
- Development of Target Product Profiles for a Portfolio of CNS Compounds
- Support of a Global Commercial Team
- Development of a Life Cycle Management Strategy
- European Market Segmentation Strategy for a GI Product
- Evaluation of a Brand Plan
- Launch Planning and Support for a New Cardiovascular Product
- Development of a Global Commercial Plan
- Maximize the Effectiveness of a Small Medical Affairs Field Force
- Evaluation of Pre-Launch Preparedness
- Assessment of Launch Preparedness
- Planning and Support for a New Product Launch in Multiple European Markets
- Definition of Commercial Requirements for a Development-Stage Product
- Lifecycle Planning Project
- Pediatric Market Assessment for an In-Line Product
- Creation of a Development Plan for a New Product
- Global Launch Planning and Management
- Tactical Marketing Planning
- Enhancement of Market Research and Commercial Analytics Capabilities
- Long-Term Care Strategy
- Development of a Process for Securing Competing Drugs for Comparator Trials
- Comprehensive Brand Plan for a CNS Product
- Launch Planning and Management for a New Biotech Product
- Survey of the Electronic Medical Records Landscape
- Rescue of a New Product Launch
- Marketing Support for a New Biotech Product
- Pre-Launch Strategy Development for a New Biotech Product
- Pre-Launch Marketing Plan for a New Allergy/Respiratory Medication
- Benchmarking of Pharmaceutical Marketing Organizations
- Launch Planning and Support for a New Formulation of an Existing Cardiovascular Product
- Launch Planning and Support for a New Respiratory Medication
- Animal Rights Action Plan Development
- Launch Planning and Support for a New Oncology Product
- Improvement of a Process to Acquire Competitive Drugs for Comparison Trials
- Refinement of a Positioning Strategy for a New HIV Medication
- Competitive Analysis to Help a Brand Team Prepare for the Launch of a New Competitor
- Scenario Planning for a Product Late in Its Life Cycle
- Advisory Boards to Address Barriers to Adoption for a New Product
- Profiling of European Advocacy Organizations
- Long-Term Care Strategy Presentation
- Selling Strategy for a Product in a Complex Market Environment
- Market Assessment for a New HIV/AIDS Drug
- Marketing Training Curriculum Design
- Launch Planning and Support for a New Oncology Product
- Hypothesized Buying Process for a New Oncology Therapy
- HIV Commercial Assessment and Portfolio Strategy
- Class Designation for a New Product
- Update of the Global Commercial Strategy for a Leading Osteoporosis Product
- Update of the Global Commercial Strategy for a Leading Oncology Product
- Assessment of the Impact of New ASCO Treatment Guidelines on Use of a Leading Oncology Therapy
- Evaluation of a Pre-Launch Brand Plan
- Support for the Global Launch of a New Oncology Product
- Global Launch Playbook (TM)
- Customization of Call Center Database to Improve Analysis Capabilities
- Review of Managed Markets Sales Team
- Commercial Assessment of a Product For Two Indications
- Review and Standardization of Launch Best Practices
- Disease State Training Program Development and Facilitation
- Management of Company-Wide Launch Preparation Activities
- Specialty Pharmacy Distribution Strategy
- Practice Management Strategy
- Development and Management of Launch Playbook
- Development of Post Launch Product Strategy
- Development of Strategies to Address Barriers to Adoption
- Market Assessment to Prepare for Product Launch
- Development of Comprehensive Commercial Plan
- Development of Commercial Strategy
- Developed SOPs For Thought Leader Management Activities
- "Launch Playbook" To Guide Launch Activities
- Manual of Commercial Best Practices
- Revenue Forecasts for Two Pharmaceutical Products
- Development and Management of a Brand Strategy Summit Meeting
- Launch Playbook For Product Launch in US and Europe
- Strategic Plan Review
- OTC Product Assessment
- Strategic Plan Development For US Product Launch
- European Commercial Strategy for a New Extended-Dosage Form of an Existing Product
- Commercial Strategy for a New Oncology Product
- Process Improvement for a Leading Pharmaceutical Company's Marketing Operations Department
- Expansion and Restructuring of a Leading Biotech's Commercial Support Organization
- Improvement of Sales Performance in an Under-Performing Sales Region
- Development of a Selling Model for a Specialized Pre-Launch Product
- Commercial Opportunity Assessment and Strategic Planning to Guide Development of a Phase III Dermatology Product
- Pricing Strategy for an Orphan Drug
- Comprehensive Commercial Planning for a New Biotech Product
- Commercial Planning for a Pre-Launch Product
- Stratgy to Help a Leading Product Penetrate the In-Patient Market
- Improvement of Commercial Planning Processes for a Leading Biotech Firm
- Comprehensive "Launch Playbooks"
- Update of a Successful Selling Strategy
- Strategy to Maximize the Uptake of a Recently Launched Brand
- Development Strategy for a Medical Device/Drug
- Unified Strategic Planning Process for a Biologic That Was Marketed in Numerous Therapeutic Areas
- Development of a "Disease Dossier" to Inform Commercial Planning
- Planning for a Product Launch in the EU
- Strategy to Help a Client Wrest Market Share From An Established Competitor
- Development and Updating of a Global Commercial Plan
- Market Research to Inform the Commercial Strategy for a New Oncology Product
- Successful Launch Planning and Execution
- Strategy to Turn Around an Underperforming Product
- Strategy Summit for a Recently Launched, Potential "Blockbuster" Product
- Strategy to Enhance the Commercial Performance of a Potential "Blockbuster"
- Long-Term Commercial Strategy for a New Oncology Product
- Life Cycle Management Strategy
- Comprehensive "Launch Playbook" to Ensure the Successful Launch of a New Biotech Product
- Assessment of the Market Potential of a New Product Combining Two Diabetes Medications
- Business Plan for a Nephrology Drug's Potential Entry into the Assisted Living Facility Market Segment
- Pre-Launch Planning and Project Management Assistance
- Pre-Launch Logistical Planning
- Critical Assistance to a Pharma-Focused Advertising Agency
- Assessment and Prioritization of Potential New Indications for a Marketed Product
- Competitive War-Gaming to Help Refine the Brand Strategies for Two Leading Products
- Comprehensive Enhancement of a Biotech Firm's Commercial Organization
- "Launch Playbook" Development for a Phase III Product
- Comprehensive Launch Planning for a New Oncology Product
- Business Case to Assess the Commercial Opportunity Associated with a New Dosing Schedule for an Established Brand
- Assessment of the Opportunity Associated with a New Indication for a Marketed Product
- Development of a Pricing Strategy
- Generic Defense Strategy
- New Market Opportunity Assessment for a Healthcare IT Firm
- Establishment of a Marketing Excellence Program for a Mid-Sized Biotech Firm
- Analysis of a Leading Pharmaceutical Firm's Human Health Portfolio to Identify Products Also Suited for the Animal Health Market
- Development of a “Shadow Brand Plan” to Help a Client Prepare for the Launch of a New Competitive Product
- Analysis of a Portfolio of Products and Recommendations for Improving ROI
- Launch Strategy and Planning for a Product in Phase III Development
- Comprehensive Brand Plan for a Product in Phase III Development
- Development of a Commercial Planning Process for the US Division of a Japanese Pharmaceutical Company
- Market Segmentation Strategy for a CNS Brand
- Assessment of a Pediatric Indication for a Global Mega-Brand
- Pricing Research for a Leading CNS Brand
- Strategic Planning for a Leading Adjunct Therapy in Oncology
- Commercial Strategy Development and Launch Planning for a Compound in Phase III Development
- Development of a Treatment Flow Model to Help Assess a New Indication for a Marketed Product
- Assessment of the Market Opportunity Represented by a New Indication for a Marketed Product
- Redesign and Enhancement of a Specialized European Development Team for a Leading Biotech Company
- Comprehensive Pre-Launch Planning for a New Pharmaceutical Product
- Market Assessment and Commercial Strategy Development for a Pre-Launch Product
- Comprehensive Market Assessment to Determine Whether a Top Biotech Firm Should Market Its Lead Product in the Critical Care Environment
- Development and Testing of a Clinical Rationale for the Use of a Marketed Product to Treat a New Indication
- Development of a System to Prioritize and Assess Potential New Indications for a Marketed Product
- Assessment of the European Market Potential of a New Indication for a Marketed Product and Development of a Commercialization Strategy
- Assessment of the Market Potential of a New Indication for a Marketed Product
- Development of a Business Case to Assess the Market Potential of a New Indication for a Marketed Product
- Development of a Business Case and Forecasts to Support the European Launch of a Biologic Product
- Market Assessment of a New Indication for a Leading Marketed Product
- Assessment of a New Indication for the European Market
- Analysis of the Impact of a New Dosing Algorithm on Product Sales
- Analysis of Sampling's ROI and Ability to Affect Prescription Decisions
- Pre-Launch Audit for a Potential Blockbuster
- Strategic Plan to Better Coordinate the Sales and Marketing Functions of a Leading Biotech Firm
- Development of a Global Commercial Plan for a Large Biotech Firm
- Enhancement of a Strategic Brand Plan
- Development of an Account Management Process for Use in the European Union
- Online Marketing Plan for a New Lifestyle Product
- Turn-Around of an Underperforming European Business Unit
- Development of a Marketing Strategy for Healthcare Communication Products
- Tactical Planning Assistance for the Marketing Team at a Diagnostic Company
- Market Potential Assessment of a Diagnostic Product at a Leading Pharmaceutical Company
- Development of Promotional Strategy for a Brand at a Leading Pharmaceutical Company
- Raynaud’s Disease Market Research for a Leading Pharmaceutical Company
- Assessment of the Commercialization Potential of an Orphan Drug for a Leading Pharmaceutical Company
- Development and Implementation of a Strategic Brand Plan for a Leading Pharmaceutical Company
- Development and Management of a Product Launch for a Leading Pharmaceutical Company
- Assessment of Potential Contracting Strategies for a Product from a Leading Pharmaceutical Company
- Development of a Health Economics Research Plan for a Leading Biotechnology Company’s Key Product
- Development of a Comprehensive Business Plan for the European Marketing Operations of a Leading Biotech Company
- Recommendations to Improve the Efficiency and Useability of a Client’s Global HIV Intranet Site
- Comprehensive Strategy and Support to Significantly Enhance the Sales of an Under-Performing Biologic Product
- Focus Group Discussion to Help a Genomics Company Explore Opportunities in Proteomics
- In-Depth Market Research for a Leading Genomics Company
- Reorganization of a “Top 10” Pharmaceutical Company’s E-Marketing Function
- Methodology to Screen and Prioritize Potential New Indications for a Biopharmaceutical Product
- Pre-Launch Strategy to Gain Early Market Share by Offering Rebates to Select PBMs.
- Development of an Innovative Selling Strategy and Training Program to Help a New Brand Steal Market Share from a Firmly Entrenched Competitor
- Market Assessment, Clinical Development, and Market Entry Strategies for a Novel CHF Therapy
- Development of a Decision-Making Tool to Help an e-Business Team Allocate Online Promotional Resources Across a Portfolio of Brands
- Web-Based DTC Strategy to Support the Launch of a New Product in a Competitive Market
- Pre-Launch Strategy for Capitalizing on Selling Opportunities in the Online Environment
- Development of an Extranet for Investigators and Key Opinion Leaders
- Web-Based Strategy to Increase Awareness Among Psychiatrists
- Development of a Suite of Web-Enabled Disease-Management Programs
- Development of a Web-Based Disease-Screening Tool for Consumers
- Facilitation of a Cross-Industry Collaboration
- Comprehensive Strategic Marketing Plan for a Healthcare Internet Company
- Evaluation of the Business Potential of a Healthcare Software Product
- Development of a Plan to Market Healthcare Informatics Products
- Combined Business Development and Marketing Strategy
- Web Strategy to Drive Increased Usage of a Non-Promoted Compound
- E-Alliance Strategy and Implementation
- Pre-Launch Strategy to Support a New Product Indication in a New Market
- Strategy to Build Competitive Advantage on the Web through Early Development of Content and Partnerships
- Web Strategy to Support Launch-Year Marketing Objectives
- Opportunity Assessment and Business Plan for a Large Pharmaceutical Outsourcing Firm
- in Order to Secure Sale of the Client
